OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nanoparticle-based DNA vaccine protects against SARS-CoV-2 variants in female preclinical models
Lays Cordeiro Guimarães, Pedro Augusto Carvalho Costa, Sérgio Scalzo, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 18
Lays Cordeiro Guimarães, Pedro Augusto Carvalho Costa, Sérgio Scalzo, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 18
Showing 18 citing articles:
Ionizable Lipid Nanoparticle-Mediated TRAIL mRNA Delivery in the Tumor Microenvironment to Inhibit Colon Cancer Progression
Walison da Silva, Pedro Augusto Carvalho Costa, Sérgio Ricardo Scalzo Júnior, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2655-2673
Open Access | Times Cited: 11
Walison da Silva, Pedro Augusto Carvalho Costa, Sérgio Ricardo Scalzo Júnior, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2655-2673
Open Access | Times Cited: 11
High-Throughput In Vivo Screening Identifies Differential Influences on mRNA Lipid Nanoparticle Immune Cell Delivery by Administration Route
Alex G. Hamilton, Kelsey L. Swingle, Ajay S. Thatte, et al.
ACS Nano (2024) Vol. 18, Iss. 25, pp. 16151-16165
Closed Access | Times Cited: 5
Alex G. Hamilton, Kelsey L. Swingle, Ajay S. Thatte, et al.
ACS Nano (2024) Vol. 18, Iss. 25, pp. 16151-16165
Closed Access | Times Cited: 5
Advances in nucleic acid-based cancer vaccines
Hung‐Chun Liao, Shih‐Jen Liu
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access
Hung‐Chun Liao, Shih‐Jen Liu
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access
Global research hotspots and trends in DNA vaccine research: A bibliometric and visualization study from 2014 to 2024
Juan Zhang, Haiguo Zhang, Cuicui Yao, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Juan Zhang, Haiguo Zhang, Cuicui Yao, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Safer non-viral DNA delivery using lipid nanoparticles loaded with endogenous anti-inflammatory lipids
Manthan N. Patel, Sachchidanand Tiwari, Yufei Wang, et al.
Nature Biotechnology (2025)
Closed Access
Manthan N. Patel, Sachchidanand Tiwari, Yufei Wang, et al.
Nature Biotechnology (2025)
Closed Access
Alveolar macrophage endosomal-lysosomal system: potential therapeutic targets for COVID-19
Yungang Lan, Gaili Wang, Zhenzhen Wang, et al.
Animals and zoonoses. (2025)
Open Access
Yungang Lan, Gaili Wang, Zhenzhen Wang, et al.
Animals and zoonoses. (2025)
Open Access
Boosting DNA vaccine power by lipid nanoparticles surface engineered with amphiphilic bioresorbable copolymer
Chung‐Hsiang Yang, Kuan‐Yin Shen, Hui‐Min Ho, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102261-102261
Open Access | Times Cited: 3
Chung‐Hsiang Yang, Kuan‐Yin Shen, Hui‐Min Ho, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102261-102261
Open Access | Times Cited: 3
Lipid nanoparticle-encapsulated DNA vaccine confers protection against swine and human-origin H1N1 influenza viruses
The Nhu Nguyen, Danh Cong Lai, Sarah Sillman, et al.
mSphere (2024) Vol. 9, Iss. 8
Open Access | Times Cited: 2
The Nhu Nguyen, Danh Cong Lai, Sarah Sillman, et al.
mSphere (2024) Vol. 9, Iss. 8
Open Access | Times Cited: 2
Structuring lipid nanoparticles, DNA, and protein corona into stealth bionanoarchitectures for in vivo gene delivery
Serena Renzi, Luca Digiacomo, Daniela Pozzi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Serena Renzi, Luca Digiacomo, Daniela Pozzi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
New insights for the development of efficient DNA vaccines
Simone Berger, Yanira Zeyn, Ernst Wagner, et al.
Microbial Biotechnology (2024) Vol. 17, Iss. 11
Open Access | Times Cited: 2
Simone Berger, Yanira Zeyn, Ernst Wagner, et al.
Microbial Biotechnology (2024) Vol. 17, Iss. 11
Open Access | Times Cited: 2
COVID-19 : vaccination , therapeutics and a review of the science and public health
Sanjit Kumar Shah, Kritick Bhandari, Avish Shah, et al.
Annals of Medicine and Surgery (2024)
Open Access | Times Cited: 1
Sanjit Kumar Shah, Kritick Bhandari, Avish Shah, et al.
Annals of Medicine and Surgery (2024)
Open Access | Times Cited: 1
Lipid nanoparticle encapsulation of a Delta spike-CD40L DNA vaccine improves effectiveness against Omicron challenge in Syrian hamsters
Levi Tamming, Diana Duque, Jegarubee Bavananthasivam, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 3, pp. 101325-101325
Open Access | Times Cited: 1
Levi Tamming, Diana Duque, Jegarubee Bavananthasivam, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 3, pp. 101325-101325
Open Access | Times Cited: 1
Cryoprotectant optimization for enhanced stability and transfection efficiency of pDNA-loaded ionizable lipid nanoparticles
Heloísa Athaydes Seabra Ferreira, Sérgio Scalzo, Kevin Kelton Santos de Faria, et al.
International Journal of Pharmaceutics (2024) Vol. 665, pp. 124696-124696
Closed Access | Times Cited: 1
Heloísa Athaydes Seabra Ferreira, Sérgio Scalzo, Kevin Kelton Santos de Faria, et al.
International Journal of Pharmaceutics (2024) Vol. 665, pp. 124696-124696
Closed Access | Times Cited: 1
DNA origami-based nano-vaccines for cancer immunotherapy
Tanvir Ahmed
Nano Trends (2024) Vol. 8, pp. 100060-100060
Closed Access | Times Cited: 1
Tanvir Ahmed
Nano Trends (2024) Vol. 8, pp. 100060-100060
Closed Access | Times Cited: 1
Protective Efficacy of a Novel DNA Vaccine with a CL264 Molecular Adjuvant against Toxoplasma gondii in a Murine Model
Kunping Ju, Yunnan Zhang, Zhaolin Xu, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 577-577
Open Access
Kunping Ju, Yunnan Zhang, Zhaolin Xu, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 577-577
Open Access
PLA-PEG as an alternative to PEGylated lipids for nanoparticle-based DNA vaccination against SARS-CoV-2
Walison N. Silva, Pedro H. D. M. Prazeres, Pedro Pires Goulart Guimarães
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102293-102293
Closed Access
Walison N. Silva, Pedro H. D. M. Prazeres, Pedro Pires Goulart Guimarães
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102293-102293
Closed Access
Pooled nanoparticle screening using a chemical barcoding approach
Katherine Vaidya, Michael S. Regan, Cheng‐An J. Lin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Katherine Vaidya, Michael S. Regan, Cheng‐An J. Lin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Human Brain In Vitro Model for Pathogen Infection-Related Neurodegeneration Study
Yuwei Yan, Ann‐Na Cho
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6522-6522
Open Access
Yuwei Yan, Ann‐Na Cho
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6522-6522
Open Access
